[Update on postcoital hormonal contraception. Part 1]
Review
OA: closed
CC0
AI-generated summary
This article reviews recent protocols for postcoital hormonal contraception, comparing the efficacy and side-effect profiles of low-dose estrogen-progestin combinations, progesterone alone, quingestanol acetate, and danazol.
One-sentence paraphrase of the abstract; not a substitute for reading it. No clinical advice. How this works
Abstract
In recent years new protocols of post-coital hormonal contraception have been devised that cause fewer side-effects. 0.2 mg ethinyl-estradiol with 2 mg norgestrel twice within 72 hours after intercourse were among the first combinations that would utilize low doses of hormones. Other authors use even smaller doses; preparations for intramuscular injection are available if the woman vomits the tablets. Progesterone has been used alone within 12 hours following intercourse with a success rate close to estrogen-progestin combinations. Quingestanol acetate is used for 5 days, 0.9-1.5 mg/day. With danazol fewer side-effects are seen; 400 mg are taken twice within 72 hours with a good rate of success.
My notes (saved in your browser only)
MeSH descriptors
Citation neighborhood (no data yet)
We don't have any in-corpus citations linked to this paper yet. The paper's references may be in our DB but unresolved to ``paper_id`` (resolution happens at ingest when the cited DOI matches a row we already have). Run the cross-source citation reconcile pass to retry.
Source provenance
- openalex
- last seen: 2026-05-10T11:29:38.281912+00:00
- pubmed
- last seen: 2026-10-08T21:00:45.472718+00:00
License: CC0
· commercial use OK